Skip to content

The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)

CompletedNot applicableNCT02155283
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the efficacy of the Kyrobak continuous passive motion home-use device in relieving low back pain, improving proprioception (balance and fall prevention) and improving the symmetry of muscle function on either side of the spine.

Study details

Official title
The Kyrobak Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Pilot Study
Conditions
Interventions
  • Device: Continuous Passive Motion
Sponsor
Radiancy
Start date
2013-10
Primary completion
2013-12
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male or female, age 18 or older * Level of pain - mild to moderate low back pain (≤5 NRS pain) * Chronic - symptoms must have been present for at least 12 weeks or more. * Location - lower tip of scapula to back of pelvis * Etiology - non-specific Exclusion Criteria: * Patients who have low back pain due to specific and known causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome (radiating nerve pain from the spine such as sciatica), cauda equinal syndrome (serious neurological disorder where the spinal nerve roots are compressed which can cause). * Weight in excess of 265 lbs. (120.4 kg) * Pregnant or breastfeeding * Recent history of violent trauma * History of previous back surgery * Constant progressive, non-mechanical pain (no relief with bed rest) * Chronic pain other than low back pain * Past medical history of malignant tumor * Has taken an investigational drug within the past 30 days prior to entering the study, or currently enrolled in another investigational study * Mental disorder that would lead to difficulty in questionnaire completion * Any litigation for low back pain * Prolonged use of corticosteroids (i.e. used for 3 months or more) * Present use of prescription pain medication (i.e. Percocet®, Oxycodone, Vicodin®, etc.) * Physical disability that prevents the subject to lie down/get up * Drug abuse, immunosuppression, HIV * Any other condition which in the physician's opinion would make it unsafe for the subject to be treated.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02155283